Stage I Testicular Seminoma AJCC v6 and v7

specific

Stage I includes: pT1-4, N0, M0, SX. pT1: Tumor limited to the testis and epididymis without vascular/lymphatic invasion; tumor may invade into the tunica albuginea but not the tunica vaginalis. pT2: Tumor limited to the testis and epididymis with vascular/lymphatic invasion, or tumor extending through the tunica albuginea with involvement of the tunica vaginalis. pT3: Tumor invades the spermatic cord with or without vascular/lymphatic invasion. pT4: Tumor invades the scrotum with or without

68

Centers

68

Active Trials

Cancer Funding

Top Centers for Stage I Testicular Seminoma AJCC v6 and v7(68)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
50.7
2
NCI Comprehensive
Active Research Program
50.7
3
NCI Comprehensive
Active Research Program
50.7
4
NCI Comprehensive
Active Research Program
50.7
5
NCI Comprehensive
Active Research Program
50.7
6
NCI Comprehensive
Active Research Program
50.7
7
NCI Comprehensive
Active Research Program
50.7
8
NCI Comprehensive
Active Research Program
50.7
9
NCI Comprehensive
Active Research Program
50.7
10
NCI Comprehensive
Active Research Program
50.7
11
NCI Comprehensive
Active Research Program
50.7
12
NCI Comprehensive
Active Research Program
50.7
13
NCI Comprehensive
Active Research Program
50.7
14
NCI Comprehensive
Active Research Program
50.7
15
NCI Comprehensive
Active Research Program
50.7
16
NCI Comprehensive
Active Research Program
50.7
17
NCI Comprehensive
Active Research Program
50.7
18
NCI Comprehensive
Active Research Program
50.7
19
NCI Comprehensive
Active Research Program
50.7
2050.7
21
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
50.7
22
NCI Comprehensive
Active Research Program
50.7
23
NCI Comprehensive
Active Research Program
50.7
24
NCI Comprehensive
Active Research Program
50.7
25
NCI Comprehensive
Active Research Program
50.7
26
NCI Comprehensive
Active Research Program
50.7
27
NCI Clinical
Active Research Program
50.7
28
NCI Comprehensive
Active Research Program
50.7
29
NCI Comprehensive
Active Research Program
50.7
30
NCI Comprehensive
Active Research Program
50.7
31
NCI Comprehensive
Active Research Program
50.7
32
NCI Comprehensive
Active Research Program
50.7
33
NCI Clinical
Active Research Program
50.7
34
NCI Comprehensive
Active Research Program
50.7
35
Active Research Program
50.7
36
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
50.7
37
NCI Comprehensive
Active Research Program
50.7
38
Active Research Program
50.7
39
Active Research Program
50.7
40
NCI Comprehensive
Active Research Program
50.7
41
NCI Comprehensive
Active Research Program
50.7
42
NCI Clinical
Active Research Program
50.7
43
NCI Comprehensive
Active Research Program
50.7
44
NCI Comprehensive
Active Research Program
50.7
45
NCI Comprehensive
Active Research Program
50.7
46
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
50.7
47
Active Research Program
50.7
48
NCI Clinical
Active Research Program
50.7
49
NCI Comprehensive
Active Research Program
50.7
50
Active Research Program
50.7
51
Active Research Program
50.7
5250.7
53
Active Research Program
50.7
54
Active Research Program
50.7
55
Active Research Program
50.7
56
Active Research Program
50.7
57
Active Research Program
50.7
58
Active Research Program
50.7
59
Active Research Program
50.7
60
Active Research Program
50.7
61
Active Research Program
50.7
6250.7
63
Active Research Program
50.7
64
Active Research Program
50.7
65
Active Research Program
50.7
66
Active Research Program
50.7
67
BC CancerVancouver, BC
Active Research Program
50.7
68
Active Research Program
50.7

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →